The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:917-918 September 24, 1998 Number 13
NextNext

Chloramphenicol Resistance in Meningococci

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Galimand, M.
-PubMed Citation
The familiar triad of pathogens responsible for most cases of bacterial meningitis was first shown to yield to treatment with {beta}-lactam antibiotics and chloramphenicol over four decades ago. Chloramphenicol proved to be an effective alternative for the treatment of pneumococcal and meningococcal disease in patients who were allergic to penicillin and was particularly effective in treating meningitis caused by Haemophilus influenzae. Chloramphenicol's loss of favor began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anemia, reversible on cessation of therapy, and an irreversible, "idiosyncratic" aplastic anemia, which had an . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.